Clinical Trial

Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
A randomized, open-label, single-dose, 2-sequence, 2-period, crossover clinical trial to investigate the bioequivalence between YHP2511 and YHP2511A in healthy volunteers
Protocol Amendment History 2 changes
critical Trial completed 2026-07-23
critical Recruitment opened 2026-06-03
Trial Details
NCT Number NCT07470125
Lead Sponsor Yuhan Corporation
Conditions Healthy Subjects
Enrollment 61 participants
Start Date 2026-06-23
Primary Completion 2026-07-11 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-22